[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2017 [#2]

Stock

[PHARMA] PHARMANIAGA BHD

Announcement Date

16-Aug-2017

Admission Sponsor

Sponsor

Financial Year

31-Dec-2017

Quarter

30-Jun-2017 [#2]

Profit Trend

QoQ- 50.31%

YoY- -14.77%

Quarter Report

PHARMA's Financial Summary

View:

Show?

YoY %

Horiz. %

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Cumulative Result
Revenue	1,465,684	1,387,998	1,200,652	1,136,261	1,090,991	984,749	993,744	6.68%
YoY %	5.60%	15.60%	5.67%	4.15%	10.79%	-0.91%	-	-
Horiz. %	147.49%	139.67%	120.82%	114.34%	109.79%	99.09%	100.00%	-
PBT	45,206	42,724	40,677	37,927	48,025	63,668	62,781	-5.32%
YoY %	5.81%	5.03%	7.25%	-21.03%	-24.57%	1.41%	-	-
Horiz. %	72.01%	68.05%	64.79%	60.41%	76.50%	101.41%	100.00%	-
Tax	-13,184	-13,814	-17,322	-8,918	-13,914	-15,100	-20,178	-6.84%
YoY %	4.56%	20.25%	-94.24%	35.91%	7.85%	25.17%	-	-
Horiz. %	65.34%	68.46%	85.85%	44.20%	68.96%	74.83%	100.00%	-
NP	32,022	28,910	23,355	29,009	34,111	48,568	42,603	-4.64%
YoY %	10.76%	23.79%	-19.49%	-14.96%	-29.77%	14.00%	-	-
Horiz. %	75.16%	67.86%	54.82%	68.09%	80.07%	114.00%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
NP to SH	32,378	28,898	22,980	28,443	33,374	48,011	42,192	-4.31%
YoY %	12.04%	25.75%	-19.21%	-14.77%	-30.49%	13.79%	-	-
Horiz. %	76.74%	68.49%	54.47%	67.41%	79.10%	113.79%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Tax Rate	29.16%	32.33%	42.58%	23.51%	28.97%	23.72%	32.14%	-
YoY %	-9.81%	-24.07%	81.11%	-18.85%	22.13%	-26.20%	-	-
Horiz. %	90.73%	100.59%	132.48%	73.15%	90.14%	73.80%	100.00%	-
Total Cost	1,433,662	1,359,088	1,177,297	1,107,252	1,056,880	936,181	951,141	7.07%
YoY %	5.49%	15.44%	6.33%	4.77%	12.89%	-1.57%	-	-
Horiz. %	150.73%	142.89%	123.78%	116.41%	111.12%	98.43%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Net Worth	357,891	518,564	519,642	541,894	524,041	527,991	502,162	-5.48%
YoY %	-30.98%	-0.21%	-4.11%	3.41%	-0.75%	5.14%	-	-
Horiz. %	71.27%	103.27%	103.48%	107.91%	104.36%	105.14%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Dividend
Div	22,204	22,149	23,383	20,742	23,302	36,234	20,707	1.16%
YoY %	0.25%	-5.28%	12.73%	-10.99%	-35.69%	74.98%	-	-
Horiz. %	107.23%	106.96%	112.92%	100.17%	112.53%	174.98%	100.00%	-
Div Payout %	68.58%	76.65%	101.76%	72.93%	69.82%	75.47%	49.08%	-
YoY %	-10.53%	-24.68%	39.53%	4.45%	-7.49%	53.77%	-	-
Horiz. %	139.73%	156.17%	207.33%	148.59%	142.26%	153.77%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Equity
Net Worth	357,891	518,564	519,642	541,894	524,041	527,991	502,162	-5.48%
YoY %	-30.98%	-0.21%	-4.11%	3.41%	-0.75%	5.14%	-	-
Horiz. %	71.27%	103.27%	103.48%	107.91%	104.36%	105.14%	100.00%	-
NOSH	261,705	261,229	259,821	259,279	258,913	258,819	258,846	0.18%
YoY %	0.18%	0.54%	0.21%	0.14%	0.04%	-0.01%	-	-
Horiz. %	101.10%	100.92%	100.38%	100.17%	100.03%	99.99%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Ratio Analysis
NP Margin	2.18%	2.08%	1.95%	2.55%	3.13%	4.93%	4.29%	-
YoY %	4.81%	6.67%	-23.53%	-18.53%	-36.51%	14.92%	-	-
Horiz. %	50.82%	48.48%	45.45%	59.44%	72.96%	114.92%	100.00%	-
ROE	9.05%	5.57%	4.42%	5.25%	6.37%	9.09%	8.40%	-
YoY %	62.48%	26.02%	-15.81%	-17.58%	-29.92%	8.21%	-	-
Horiz. %	107.74%	66.31%	52.62%	62.50%	75.83%	108.21%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Per Share
RPS	561.06	532.65	462.11	438.24	421.37	380.48	383.91	6.52%
YoY %	5.33%	15.26%	5.45%	4.00%	10.75%	-0.89%	-	-
Horiz. %	146.14%	138.74%	120.37%	114.15%	109.76%	99.11%	100.00%	-
EPS	12.39	11.09	8.84	10.97	12.89	18.55	16.30	-4.46%
YoY %	11.72%	25.45%	-19.42%	-14.90%	-30.51%	13.80%	-	-
Horiz. %	76.01%	68.04%	54.23%	67.30%	79.08%	113.80%	100.00%	-
DPS	8.50	8.50	9.00	8.00	9.00	14.00	8.00	1.01%
YoY %	0.00%	-5.56%	12.50%	-11.11%	-35.71%	75.00%	-	-
Horiz. %	106.25%	106.25%	112.50%	100.00%	112.50%	175.00%	100.00%	-
NAPS	1.37	1.99	2.00	2.09	2.024	2.04	1.94	-5.62%
YoY %	-31.16%	-0.50%	-4.31%	3.26%	-0.78%	5.15%	-	-
Horiz. %	70.62%	102.58%	103.09%	107.73%	104.33%	105.15%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Adjusted Per Share Value based on latest NOSH - 259,400
RPS	101.70	96.31	83.31	78.84	75.70	68.33	68.95	6.68%
YoY %	5.60%	15.60%	5.67%	4.15%	10.79%	-0.90%	-	-
Horiz. %	147.50%	139.68%	120.83%	114.34%	109.79%	99.10%	100.00%	-
EPS	2.25	2.01	1.59	1.97	2.32	3.33	2.93	-4.30%
YoY %	11.94%	26.42%	-19.29%	-15.09%	-30.33%	13.65%	-	-
Horiz. %	76.79%	68.60%	54.27%	67.24%	79.18%	113.65%	100.00%	-
DPS	1.54	1.54	1.62	1.44	1.62	2.51	1.44	1.12%
YoY %	0.00%	-4.94%	12.50%	-11.11%	-35.46%	74.31%	-	-
Horiz. %	106.94%	106.94%	112.50%	100.00%	112.50%	174.31%	100.00%	-
NAPS	0.2483	0.3598	0.3606	0.376	0.3636	0.3663	0.3484	-5.48%
YoY %	-30.99%	-0.22%	-4.10%	3.41%	-0.74%	5.14%	-	-
Horiz. %	71.27%	103.27%	103.50%	107.92%	104.36%	105.14%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Price Multiplier on Financial Quarter End Date
Date	30/06/20	28/06/19	29/06/18	30/06/17	30/06/16	30/06/15	30/06/14	-
Price	2.22	2.84	2.88	4.58	5.50	7.13	4.61	-
P/RPS	0.40	0.53	0.62	1.05	1.31	1.87	1.20	-16.71%
YoY %	-24.53%	-14.52%	-40.95%	-19.85%	-29.95%	55.83%	-	-
Horiz. %	33.33%	44.17%	51.67%	87.50%	109.17%	155.83%	100.00%	-
P/EPS	17.91	25.61	32.56	41.75	42.67	38.44	28.28	-7.32%
YoY %	-30.07%	-21.35%	-22.01%	-2.16%	11.00%	35.93%	-	-
Horiz. %	63.33%	90.56%	115.13%	147.63%	150.88%	135.93%	100.00%	-
EY	5.58	3.90	3.07	2.40	2.34	2.60	3.54	7.87%
YoY %	43.08%	27.04%	27.92%	2.56%	-10.00%	-26.55%	-	-
Horiz. %	157.63%	110.17%	86.72%	67.80%	66.10%	73.45%	100.00%	-
DY	3.83	2.99	3.13	1.75	1.64	1.96	1.74	14.03%
YoY %	28.09%	-4.47%	78.86%	6.71%	-16.33%	12.64%	-	-
Horiz. %	220.11%	171.84%	179.89%	100.57%	94.25%	112.64%	100.00%	-
P/NAPS	1.62	1.43	1.44	2.19	2.72	3.50	2.38	-6.20%
YoY %	13.29%	-0.69%	-34.25%	-19.49%	-22.29%	47.06%	-	-
Horiz. %	68.07%	60.08%	60.50%	92.02%	114.29%	147.06%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Price Multiplier on Announcement Date
Date	19/08/20	23/08/19	17/08/18	16/08/17	19/08/16	17/08/15	21/08/14	-
Price	4.42	2.66	3.11	4.19	5.62	5.65	4.62	-
P/RPS	0.79	0.50	0.67	0.96	1.33	1.48	1.20	-6.72%
YoY %	58.00%	-25.37%	-30.21%	-27.82%	-10.14%	23.33%	-	-
Horiz. %	65.83%	41.67%	55.83%	80.00%	110.83%	123.33%	100.00%	-
P/EPS	35.66	23.99	35.16	38.20	43.60	30.46	28.34	3.89%
YoY %	48.65%	-31.77%	-7.96%	-12.39%	43.14%	7.48%	-	-
Horiz. %	125.83%	84.65%	124.06%	134.79%	153.85%	107.48%	100.00%	-
EY	2.80	4.17	2.84	2.62	2.29	3.28	3.53	-3.78%
YoY %	-32.85%	46.83%	8.40%	14.41%	-30.18%	-7.08%	-	-
Horiz. %	79.32%	118.13%	80.45%	74.22%	64.87%	92.92%	100.00%	-
DY	1.92	3.20	2.89	1.91	1.60	2.48	1.73	1.75%
YoY %	-40.00%	10.73%	51.31%	19.37%	-35.48%	43.35%	-	-
Horiz. %	110.98%	184.97%	167.05%	110.40%	92.49%	143.35%	100.00%	-
P/NAPS	3.23	1.34	1.56	2.00	2.78	2.77	2.38	5.21%
YoY %	141.04%	-14.10%	-22.00%	-28.06%	0.36%	16.39%	-	-
Horiz. %	135.71%	56.30%	65.55%	84.03%	116.81%	116.39%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Featured Posts

Moomoo MY

Don't Miss Out: Up to USD1,000 in Our Lucky Draw!

Latest Videos

MQ Market Updates - 15 May 2024

MQ Trader

MQ Trading Signals

2024-05-16 12:00:00

EMA 5

30 Mins

BUY

2024-05-16 11:50:00

EMA 5

10 Mins

BUY

2024-05-16 11:45:00

EMA 5

5 Mins

BUY

2024-05-16 11:45:00

ADX

5 Mins

BUY

2024-05-16 10:20:00

EMA 5

5 Mins

SELL

More Trading Signals

Apps

MQ Chat

Send individual or group chats with anyone on i3investor

MQ Trader

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

MQdemy

Online learning and teaching marketplace

Hot Stocks Today >

TOPGLOV

TOP GLOVE CORPORATION BHD

1000

TASCO

TASCO BERHAD

629

HARTA

HARTALEGA HOLDINGS BHD

564

MPI

MALAYSIAN PACIFIC INDUSTRIES

425

PTRANS

PERAK TRANSIT BERHAD

423

YTLPOWR

YTL POWER INTERNATIONAL BHD

417

HLIND

HONG LEONG INDUSTRIES BHD

417

MYEG

MY E.G. SERVICES BHD

369

MBSB

MALAYSIA BUILDING SOCIETY BHD

333

SUPERMX

SUPERMAX CORPORATION BHD

323

Daily Stocks

HSI-CXG

0.23

+0.025

277,503,800

REVENUE

0.23

-0.015

268,817,300

TOPGLOV

1.18

-0.08

232,755,600

HSI-HUZ

0.205

-0.04

223,098,800

MQTECH

0.015

-0.005

154,727,000

INIX-OR

0.02

0.00

141,839,900

CAREPLS

0.35

-0.03

89,735,300

MYEG

1.05

+0.02

81,466,300

SUPERMX

1.00

-0.08

81,058,500

HSI-CV8

0.145

+0.01

78,540,100

More active Stocks

MPI

33.82

+1.30

132,700

F&N

33.26

+0.78

168,400

UTDPLT

26.26

+0.64

256,700

HEIM

24.74

+0.54

234,700

NESTLE

129.50

+0.50

20,600

CARLSBG

20.00

+0.38

264,300

PANAMY

19.62

+0.36

16,200

KSENG

6.31

+0.33

424,300

ALLIANZ

22.00

+0.32

30,700

PENTA

4.71

+0.26

3,456,200

More gainer Stocks

AJI

16.24

-0.32

154,400

AIRPORT

10.10

-0.30

20,630,600

HARTA

3.55

-0.27

29,534,300

KOSSAN

2.50

-0.24

16,550,300

KOSSAN-C60

0.585

-0.195

341,000

AHEALTH

2.92

-0.15

700,900

ICAP

3.31

-0.13

295,200

KUAISHO-C17

0.08

-0.12

58,800

DLADY

32.82

-0.12

1,800

HARTA-C1W

0.41

-0.105

1,185,700

More loser Stocks

Featured Advertisers / Partners

Top Brokers >

AmEquities

Affin Hwang

Rakuten Trade

Hong Leong Bank

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....

Read More